Culture & Values

Print

Culture & Values

Enzon is committed to the development of therapeutics to treat cancer and other life-threatening diseases. Our commitment is driven by a set of corporate values that focus on five key elements essential to the success of our business — people, passion, performance, pride, and a steadfast commitment to delivering on our promises. These values describe who we are, how we conduct ourselves, and are founded upon a commitment to excellence.
 
People
Our employees are the foundation of our business. We are committed to cultivate an environment that attracts, motivates, and develops individuals who are committed to playing an active role in our success as a company. We respect the importance of the individual but also recognize the remarkable potential and strength of a unified team.
 
Passion
We are passionate about advancing our common goal of bringing innovative products to the marketplace to improve patient care. We have a “can do” attitude and believe in transforming possibilities into realities. We believe in ourselves, believe in Enzon’s potential, and want to be a major part of maximizing that potential.  
 
Performance
We are committed to maintaining a high-performance culture that is focused on the long-term success of Enzon. We strive for our performance to exceed the expectations of everyone we deal with in our jobs — both internally and externally. We take initiative to work independently and together to seize opportunities, indentify solutions, and overcome challenges.  
 
Pride
We take pride in maintaining high standards of quality in all that we do. We are dedicated to the people who depend on our business and our products.  
 
Promises
We believe that promises that are made must be delivered — as the success of our business rests upon our trustworthiness. We are honest and accountable for our actions.
Search
(ENZN) NASDAQ
Last Trade9.82
Change(%)price+0.01
Volume261532
News
  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 07-27-2009

    Enzon to Present at BMO Focus...

    Enzon to Present at BMO Focus on Healthcare Conference

    click here for more information

  • 07-23-2009

    Enzon Enhances Governance with...

    Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

    click here for more information

  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 05-14-2009

    UCB"s Cimzia® Approved in the...

    UCB"s Cimzia® Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
    -- Enzon to receive royalties for PEGylation technology--

    click here for more information

  • 04-23-2009

    Enzon Continues to Improve its...

    Enzon Continues to Improve its Capital Structure
    -- Company repurchased $17.5 million of its outstanding debt at a discount to par--

    click here for more information

  • 12-31-1969

    Enzon Pharmaceuticals to Add N...

    Enzon Pharmaceuticals to Add New Independent Director to Board

    click here for more information

  • 12-31-1969

    Enzon Reports Strong First Qua...

    Enzon Reports Strong First Quarter 2009 Results
    --Company continues to improve its capital structure--

    click here for more information

  • 02-13-2009

    Enzon to Release Fourth Quarte...

    Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 01-28-2009

    Enzon Nominates Two New Candid...

    Enzon Nominates Two New Candidates for its Board of Directors

    click here for more information

  • 12-08-2008

    Enzon Pharmaceuticals Commence...

    Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt

    click here for more information